Barrington Research restated their market perform rating on shares of Cross Country Healthcare (NASDAQ:CCRN – Free Report) in a research report released on Tuesday, MarketBeat.com reports. Barrington Research also issued estimates for Cross Country Healthcare’s Q4 2024 earnings at $0.12 EPS, FY2024 earnings at $0.54 EPS and FY2025 earnings at $0.55 EPS.
A number of other equities analysts also recently commented on CCRN. Truist Financial boosted their price objective on shares of Cross Country Healthcare from $15.00 to $18.61 and gave the stock a “hold” rating in a research note on Thursday, December 5th. Benchmark downgraded shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 4th. Finally, William Blair downgraded shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 4th. Four investment analysts have rated the stock with a hold rating, Based on data from MarketBeat, Cross Country Healthcare presently has an average rating of “Hold” and an average price target of $18.54.
View Our Latest Analysis on CCRN
Cross Country Healthcare Stock Up 0.1 %
Institutional Trading of Cross Country Healthcare
A number of institutional investors have recently bought and sold shares of the stock. Pacer Advisors Inc. raised its holdings in shares of Cross Country Healthcare by 3.8% in the second quarter. Pacer Advisors Inc. now owns 4,550,848 shares of the business services provider’s stock worth $62,984,000 after buying an additional 165,032 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Cross Country Healthcare by 1.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,360,016 shares of the business services provider’s stock worth $32,662,000 after acquiring an additional 24,363 shares during the last quarter. Systematic Financial Management LP lifted its position in Cross Country Healthcare by 8.5% during the 3rd quarter. Systematic Financial Management LP now owns 1,662,730 shares of the business services provider’s stock worth $22,347,000 after acquiring an additional 130,746 shares during the period. State Street Corp grew its stake in Cross Country Healthcare by 0.5% during the 3rd quarter. State Street Corp now owns 1,334,353 shares of the business services provider’s stock valued at $17,934,000 after purchasing an additional 6,582 shares during the last quarter. Finally, Royce & Associates LP increased its holdings in shares of Cross Country Healthcare by 51.4% in the third quarter. Royce & Associates LP now owns 1,132,566 shares of the business services provider’s stock valued at $15,222,000 after purchasing an additional 384,374 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Read More
- Five stocks we like better than Cross Country Healthcare
- How to Invest in Biotech Stocks
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- The Most Important Warren Buffett Stock for Investors: His Own
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Manufacturing Stocks Investing
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.